![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 2, 1634-1640, January 14, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

¶
¶||


**
From the
Departments of Neuroscience, Pharmacology and Molecular Sciences, and Psychiatry, School of Medicine, The Johns Hopkins University, Baltimore, Maryland 21205 and the
Department of Neurology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
Diphosphoinositol pentakisphosphate (InsP7) and bis-diphosphoinositol tetrakisphosphate contain pyrophosphate bonds. InsP7 is formed from inositol hexakisphosphate (InsP6) by a family of three inositol hexakisphosphate kinases (InsP6K). In this study we establish one of the InsP6Ks, InsP6K2, as a physiologic mediator of cell death. Overexpression of wild-type InsP6K2 augments the cytotoxic actions of multiple cell stressors in diverse cell lines, whereas transfection with a dominant negative InsP6K2 decreases cell death. During cell death, InsP6 kinase activity is enhanced, and intracellular InsP7 level is augmented. Deletion of InsP6K2 but not the other forms of InsP6K diminishes cell death, suggesting that InsP6K2 is the major InsP6 kinase involved in cell death. Cytotoxicity is associated with a translocation of InsP6K2 from nuclei to mitochondria, whereas the intracellular localization of the other isoforms of the enzyme does not change. The present study provides compelling evidence that endogenous InsP6K2, by generating InsP7, provides physiologic regulation of the apoptotic process.
Received for publication, August 17, 2004 , and in revised form, November 4, 2004.
* This work was funded by United States Public Health Service Grant MH-18501 and Research Scientist Grant DA-00074 (to S. H. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ These authors contributed equally to this work.
|| Present address: Depts. of Pathology and Laboratory Medicine, Harvard Medical School and Children's Hospital Boston, Karp Bldg. 10214, 300 Longwood Ave., Boston, MA 02115.
** To whom correspondence should be addressed: Tel.: 410-955-3024; Fax: 410-955-3623; E-mail: ssnyder{at}bs.jhmi.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Yang, J. M. Reece, J. Cho, C. D. Bortner, and S. B. Shears The Nucleolus Exhibits an Osmotically Regulated Gatekeeping Activity That Controls the Spatial Dynamics and Functions of Nucleolin J. Biol. Chem., April 25, 2008; 283(17): 11823 - 11831. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bhandari, K. R. Juluri, A. C. Resnick, and S. H. Snyder Gene deletion of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation of insulin secretion, growth, and spermiogenesis PNAS, February 19, 2008; 105(7): 2349 - 2353. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chakraborty, M. A. Koldobskiy, K. M. Sixt, K. R. Juluri, A. K. Mustafa, A. M. Snowman, D. B. van Rossum, R. L. Patterson, and S. H. Snyder From the Cover: HSP90 regulates cell survival via inositol hexakisphosphate kinase-2 PNAS, January 29, 2008; 105(4): 1134 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Illies, J. Gromada, R. Fiume, B. Leibiger, J. Yu, K. Juhl, S.-N. Yang, D. K. Barma, J. R. Falck, A. Saiardi, et al. Requirement of Inositol Pyrophosphates for Full Exocytotic Capacity in Pancreatic Cells Science, November 23, 2007; 318(5854): 1299 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Choi, J. Williams, J. Cho, J. R. Falck, and S. B. Shears Purification, Sequencing, and Molecular Identification of a Mammalian PP-InsP5 Kinase That Is Activated When Cells Are Exposed to Hyperosmotic Stress J. Biol. Chem., October 19, 2007; 282(42): 30763 - 30775. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bhandari, A. Saiardi, Y. Ahmadibeni, A. M. Snowman, A. C. Resnick, T. Z. Kristiansen, H. Molina, A. Pandey, J. K. Werner Jr., K. R. Juluri, et al. Protein pyrophosphorylation by inositol pyrophosphates is a posttranslational event PNAS, September 25, 2007; 104(39): 15305 - 15310. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Morrison, J. A. Bauer, J. A. Lupica, Z. Tang, H. Schmidt, J. A. DiDonato, and D. J. Lindner Effect of Inositol Hexakisphosphate Kinase 2 on Transforming Growth Factor beta-activated Kinase 1 and NF-{kappa}B Activation J. Biol. Chem., May 25, 2007; 282(21): 15349 - 15356. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohnishi, H. Ohba, K.-C. Seo, J. Im, Y. Sato, Y. Iwayama, T. Furuichi, S.-K. Chung, and T. Yoshikawa Spatial Expression Patterns and Biochemical Properties Distinguish a Second myo-Inositol Monophosphatase IMPA2 from IMPA1 J. Biol. Chem., January 5, 2007; 282(1): 637 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Holmes and G. Jogl Crystal Structure of Inositol Phosphate Multikinase 2 and Implications for Substrate Specificity J. Biol. Chem., December 8, 2006; 281(49): 38109 - 38116. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Saiardi, A. C. Resnick, A. M. Snowman, B. Wendland, and S. H. Snyder From the Cover: Inositol pyrophosphates regulate cell death and telomere length through phosphoinositide 3-kinase-related protein kinases PNAS, February 8, 2005; 102(6): 1911 - 1914. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |